Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemofiltration | 3 | 2017 | 17 | 1.510 |
Why?
|
| Brain Injuries | 3 | 2017 | 142 | 1.340 |
Why?
|
| Renal Replacement Therapy | 3 | 2017 | 23 | 1.110 |
Why?
|
| Vasospasm, Intracranial | 1 | 2021 | 30 | 0.690 |
Why?
|
| Brain Ischemia | 2 | 2021 | 421 | 0.640 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2021 | 109 | 0.630 |
Why?
|
| Thrombophilia | 1 | 2015 | 14 | 0.450 |
Why?
|
| Encephalocele | 1 | 2015 | 15 | 0.450 |
Why?
|
| Embolism, Paradoxical | 1 | 2015 | 14 | 0.450 |
Why?
|
| Brain Edema | 1 | 2015 | 31 | 0.450 |
Why?
|
| Foramen Ovale, Patent | 1 | 2015 | 13 | 0.450 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 112 | 0.420 |
Why?
|
| Decision Making | 1 | 2017 | 416 | 0.410 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 142 | 0.390 |
Why?
|
| Stroke | 1 | 2015 | 1196 | 0.240 |
Why?
|
| Oncogene Proteins | 2 | 2013 | 34 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 99 | 0.170 |
Why?
|
| Hedgehog Proteins | 2 | 2013 | 116 | 0.160 |
Why?
|
| Bed Rest | 1 | 2019 | 11 | 0.160 |
Why?
|
| Intensive Care Units | 1 | 2022 | 414 | 0.150 |
Why?
|
| Trans-Activators | 2 | 2013 | 312 | 0.150 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 193 | 0.140 |
Why?
|
| Zebrafish | 2 | 2013 | 350 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2017 | 195 | 0.120 |
Why?
|
| Middle Aged | 4 | 2019 | 17921 | 0.120 |
Why?
|
| Adolescent | 2 | 2017 | 6305 | 0.120 |
Why?
|
| Humans | 7 | 2022 | 64283 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2015 | 125 | 0.110 |
Why?
|
| Inflammation | 1 | 2021 | 1163 | 0.110 |
Why?
|
| Heat-Shock Response | 1 | 2013 | 34 | 0.100 |
Why?
|
| Male | 4 | 2019 | 30322 | 0.090 |
Why?
|
| Aged | 3 | 2019 | 14662 | 0.090 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 159 | 0.090 |
Why?
|
| Adult | 3 | 2022 | 17134 | 0.090 |
Why?
|
| Female | 4 | 2019 | 33382 | 0.090 |
Why?
|
| Prevalence | 1 | 2015 | 1407 | 0.080 |
Why?
|
| Endocrine Cells | 1 | 2008 | 10 | 0.070 |
Why?
|
| Pituitary Gland | 1 | 2008 | 51 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 4781 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2019 | 6740 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2022 | 2605 | 0.060 |
Why?
|
| Risk Factors | 1 | 2015 | 5341 | 0.060 |
Why?
|
| Glasgow Coma Scale | 1 | 2022 | 48 | 0.050 |
Why?
|
| Zinc Finger Protein GLI1 | 2 | 2013 | 31 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 2 | 2013 | 179 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2022 | 870 | 0.030 |
Why?
|
| Prognosis | 1 | 2022 | 1769 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 80 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 302 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 3725 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 375 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2013 | 3070 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 685 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5528 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 644 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2008 | 10 | 0.020 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2008 | 26 | 0.020 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2008 | 30 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5696 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 82 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1366 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 20967 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 1541 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 2633 | 0.010 |
Why?
|